Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes
Sign Up to like & getrecommendations! Published in 2021 at "Cancer"
DOI: 10.1002/cncr.33745
Abstract: SF3B1 mutations (SF3B1mut) in myelodysplastic syndromes (MDS) frequently involve codon K700E and have a favorable prognosis. The prognostic effect of non‐K700E SF3B1mut is uncertain. read more here.
Keywords: myelodysplastic syndromes; mutation involving; sf3b1 mutation; independently predicts ... See more keywords
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.905490
Abstract: The outcomes of myelodysplastic syndrome (MDS) patients with SF3B1 mutation, despite identified as a favorable prognostic biomarker, are variable. To comprehend the heterogeneity in clinical characteristics and outcomes, we reviewed 140 MDS patients with SF3B1… read more here.
Keywords: prognostic scoring; sf3b1 mutation; model; patients sf3b1 ... See more keywords